ProCE Banner Activity

Expert Guidance on Harnessing New Therapeutic Approaches in Ulcerative Colitis Slideset


Download these slides to learn how the introduction of S1P receptor modulators and JAK inhibitors for treating UC has the potential to revolutionize the therapeutic landscape. Read the latest from expert faculty on the place in therapy for these agents to help improve clinical and patient-oriented health outcomes.

Released: October 30, 2023



Marla Dubinsky

Marla Dubinsky, MD

Professor of Pediatrics and Medicine
Chief, Division of Pediatric GI and Nutrition
Co-Director, Susan and Leonard Feinstein IBD Center
Icahn School of Medicine, Mount Sinai New York
New York, New York

Corey Siegel

Corey Siegel, MD, MS

Director, Center for Digestive Health
Section Chief, Gastroenterology and Hepatology
Co-Director, Inflammatory Bowel Disease Center
Dartmouth Hitchcock Medical Center
Constantine and Joyce Hampers Professor of Medicine
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Pfizer, Inc.

Pfizer, Inc.